Liu L

13.9k citations

434 papers · 10.6k · h-index 54

Impact in

Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 1%
- Circular RNAs in diseases
- RNA modifications and cancer
- PI3K/AKT/mTOR signaling in cancer
- Angiogenesis and VEGF in Cancer
- Extracellular vesicles in disease

Papers in

Molecular Biology 143
- Circular RNAs in diseases 24
- RNA modifications and cancer 24
- Epigenetics and DNA Methylation 13
- PI3K/AKT/mTOR signaling in cancer 11
Cancer Research 91
- MicroRNA in disease regulation 49
- Cancer-related molecular mechanisms research 33
- Cancer, Hypoxia, and Metabolism 22

Co-authors: Bing‐Hua Jiang (73 shared papers)Xu Qian (18 shared papers)Jun He (19 shared papers)Jason Y. Chang (10 shared papers)Yue Jiang (7 shared papers)Qing Xu (12 shared papers)Yon Rojanasakul (4 shared papers)Hai‐Jun Jin (10 shared papers)
Journals: Oncotarget (8 papers)Biochemical and Biophysical Research Communications (8 papers)PLoS ONE (6 papers)Oncogene (4 papers)Scientific Reports (4 papers)
Partner nations: China United States Saudi Arabia

In The Last Decade

Liu L

393 papers receiving 10.5k citations

Peers

Replace Hui Li with:

Hui Li China

Thomas Kietzmann Germany

Rui Chen China

Yang Yang China

Jia Li China

Su‐Jae Lee South Korea

Baofeng Yang China

Vladimir Gogvadze Sweden

Cheng Wang China

Ling Li China

Liu L relative to Hui Li China Hui Li's profile →

Citations per field

00.5×1.5×

Hui Li · 1×

×0.9 4k/4k

CR

×0.7 6k/8k

MB

×1.2 1k/1k

ONCOL

×1.1 714/673

IMMUN

×1.4 365/268

HTM

Citations per year

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

'26

Countries citing papers authored by Liu L

Since Specialization

Citations

This map shows the geographic impact of Liu L's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liu L with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liu L more than expected).

Fields of papers citing papers by Liu L

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liu L. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liu L. The network helps show where Liu L may publish in the future.

Co-authors

The 25 scholars most cited alongside Liu L, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Liu L Line = papers co-authored together Liu L links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 434 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis Advances in cancer research ·Bing‐Hua Jiang, Liu L	2009	450
2	MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression PLoS ONE ·Liu L, Chong-Yong Li, Qi Chen, Jing Yi, Richard L. Carpenter, Yue Jiang, Hsiang‐Fu Kung, Lihui Lai, Bing‐Hua Jiang	2011	426
3	Reactive Oxygen Species Regulate Angiogenesis and Tumor Growth through Vascular Endothelial Growth Factor Cancer Research ·Chang Xia, (unknown), Liu L, Yon Rojanasakul, Xinru Wang, Bing‐Hua Jiang	2007	408
4	TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs Nature ·Xiaohua Su, Deepavali Chakravarti, Min Soon Cho, Liu L, Young Jin Gi, Yu-Li Lin, Marco L. Leung, Adel K. El‐Naggar, Chad J. Creighton, Milind Suraokar, Ignacio I. Wistuba, Elsa R. Flores	2010	353
5	PI3K/PTEN signaling in tumorigenesis and angiogenesis Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Bing‐Hua Jiang, Liu L	2007	274
6	MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis Nucleic Acids Research ·Qing Xu, Liu L, Xu Qian, Qi Chen, Yue Jiang, Dan Li, Lihui Lai, Bing‐Hua Jiang	2011	244
7	A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1 Journal of Molecular Cell Biology ·Qing Xu, Yue Jiang, Yu Yin, Qi Li, Jun He, Jing Yi, Yan-Ting Qi, Xu Qian, Wei Li, Jiahong Lu, Stephen Peiper, Bing‐Hua Jiang, Liu L	2012	243
8	Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment Drug Resistance Updates ·Bing‐Hua Jiang, Liu L	2008	201
9	Apigenin inhibits tumor angiogenesis through decreasing HIF-1 and VEGF expression Carcinogenesis ·Jie Fang, Qi Zhou, Liu L, C. Xia, Xiaotao Hu, Xiaojing Shi, Bing‐Hua Jiang	2006	185
10	PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis Cellular Signalling ·Jing Fang, Min Ding, Lily Yang, Liu L, Bing‐Hua Jiang	2007	176
11	AKT1 Amplification Regulates Cisplatin Resistance in Human Lung Cancer Cells through the Mammalian Target of Rapamycin/p70S6K1 Pathway Cancer Research ·Liu L, Xiangdong Zhou, Guisheng Qian, Xianglin Shi, Jing Fang, Bing‐Hua Jiang	2007	170
12	Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells Free Radical Biology and Medicine ·Liu L, Zhongyi Hu, Chang Xia, Jie He, Qiong Zhou, Xianglin Shi, Jing Fang, Bing‐Hua Jiang	2006	169
13	Cadmium Increases HIF-1 and VEGF Expression through ROS, ERK, and AKT Signaling Pathways and Induces Malignant Transformation of Human Bronchial Epithelial Cells Toxicological Sciences ·Jing Yi, Liu L, Yue Jiang, Yingxue Zhu, Nancy Lan Guo, John B. Barnett, Yon Rojanasakul, Faton Agani, Bing‐Hua Jiang	2011	169
14	AKT Signaling in Regulating Angiogenesis Current Cancer Drug Targets ·Bing‐Hua Jiang, Liu L	2008	165
15	Apigenin Inhibits Expression of Vascular Endothelial Growth Factor and Angiogenesis in Human Lung Cancer Cells: Implication of Chemoprevention of Lung Cancer Molecular Pharmacology ·Liu L, Jing Fang, Qiong Zhou, Zhongyi Hu, Xianglin Shi, Bing‐Hua Jiang	2005	164
16	Kaempferol Inhibits Angiogenesis and VEGF Expression Through Both HIF Dependent and Independent Pathways in Human Ovarian Cancer Cells Nutrition and Cancer ·Haitao Luo, Gary O. Rankin, Liu L, Matthew K. Daddysman, Bing‐Hua Jiang, Yi Chen	2009	153
17	Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy Autophagy ·Jun He, Jing-Jie Yu, Qing Xu, Lin Wang, Jenny Z. Zheng, Liu L, Bing‐Hua Jiang	2015	145
18	MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers Cell Cycle ·Xu Qian, Jing Yu, Yu Yin, Jun He, Ling Wang, Qi Li, Lou-Qian Zhang, Chong-yong Li, Zhu‐Mei Shi, Qing Xu, Wei Li, Li-Hui Lai, Liu L, Bing‐Hua Jiang	2013	134
19	Downregulation of miR-218 contributes to epithelial–mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling Oncogene ·Z-M Shi, L Wang, Hua Shen, (unknown), Xin Ge, Dongmei Li, Y-Y Wen, H.-F Sun, M-H Pan, W Li, Y-q Shu, Liu L, Stephen C. Peiper, Jun He, (unknown)	2017	128
20	MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6K1 PLoS ONE ·Zhu-mei Shi, Jing Wang, Zhiping Yan, Yong-ping You, Chong-yong Li, Xu Qian, Yu Yin, Peng Zhao, Yingying Wang, Xie-feng Wang, Ming-na Li, Liu L, Ning Liu, Bing‐Hua Jiang	2012	128

About Liu L

Liu L is a scholar working on Molecular Biology, Cancer Research, Oncology, Materials Chemistry and Pulmonary and Respiratory Medicine, having authored 434 papers that have together received 10.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (49 papers), Cancer-related molecular mechanisms research (33 papers), Circular RNAs in diseases (24 papers), RNA modifications and cancer (24 papers), Cancer, Hypoxia, and Metabolism (22 papers), Epigenetics and DNA Methylation (13 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and Nanoporous metals and alloys (10 papers). The work is most often cited by research in Cancer Research (3.5k citations), Molecular Biology (5.6k citations), Oncology (1.3k citations), Immunology (714 citations) and Health, Toxicology and Mutagenesis (365 citations). Liu L has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Bing‐Hua Jiang, Xu Qian, Jun He, Jason Y. Chang, Yue Jiang, Qing Xu, Yon Rojanasakul, Hai‐Jun Jin, Xinru Wang and Chang Xia. Their work appears in journals such as Oncotarget, Biochemical and Biophysical Research Communications, PLoS ONE, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Liu L

Impact in

Papers in i

In The Last Decade

Liu L

Peers

Countries citing papers authored by Liu L

Fields of papers citing papers by Liu L

All Works

About Liu L

Explore authors with similar magnitude of impact

Papers in